Form 4: Novavax Executive Filip Dubovsky Reports Stock Transactions
SEC Form 4 Filing
Filip Dubovsky, President of R&D at Novavax, exercised stock options and sold shares on May 14, 2024.
Summary
- Filip Dubovsky, President of R&D at Novavax, filed a Form 4 detailing changes in beneficial ownership.
- On May 14, 2024, Dubovsky exercised stock options to acquire 19,652 shares of common stock at a price of $6.97 per share.
- On the same day, Dubovsky sold 47,312 shares of common stock at a weighted average price of $13.90, with individual transactions ranging from $13.86 to $14.00.
- Following these transactions, Dubovsky directly owns 38,953 shares of Novavax common stock and derivative securities representing 47,728 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the trading activities of key personnel.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the volume of shares traded daily.
Key Dates
| Date | Description |
|---|---|
| 03/07/2023 | Grant date of stock options under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan. |
| 05/14/2024 | Date of stock option exercise and sale of shares. |
| 05/15/2024 | Date of signature on the Form 4 filing. |
| 03/07/2033 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.